1 February 2007
glanmark pharma

Despite recent price improvements nationally, only five markets in the country are expected to see home-price gains for the remainder of 2011: Washington, New York, Orlando, Dallas and San Francisco.
1 February 2007

29 January 2007
ivrcl is a good buy at current level target 50% upside in 6 months
Covering Brokers
Merrill Lynch,Broker Name Withheld,First Global,JPMorgan Securities Equities,Macquarie Research Equities,UBS Equities,Motilal Oswal Securities Ltd.,Enam,Kotak Securities,Prabhudas Liladher (Pvt) Ltd,Edelweiss Capital Ltd

Earning Per Share (EPS)
Actual () -->
Actual (31 Mar 2006)
8.63
Surprise
8.55
Consensus Estimates
Net Profit1 () -->
Net Profit1 (31 Mar 2007)
EPS1 () -->
EPS1 (31 Mar 2007)
11.48
Net Profit2 () -->
Net Profit2 (31 Mar 2008)
EPS2 () -->
EPS2 (31 Mar 2008)
17.35